National Institute on Alcohol Abuse and Alcoholism; Notice of Meeting, 39763-39764 [2018-17107]
Download as PDF
<![CDATA[
daltland on DSKBBV9HB2PROD with NOTICES
Federal Register / Vol. 83, No. 155 / Friday, August 10, 2018 / Notices
Washington, Center for Drug Evaluation
and Research, Food and Drug
Administration, 10903 New Hampshire
Ave., Silver Spring, MD 20993–0002,
301–796–1019, tisha.washington@
fda.hhs.gov no later than September 4,
2018.
Requests for Oral Presentations:
During online registration you may
indicate if you wish to present at the
public comment session, and which
topic(s) you wish to address. We will do
our best to accommodate requests to
make public comments. Individuals and
organizations with common interests are
urged to consolidate or coordinate their
presentations, and request time for a
joint presentation. Following the close
of registration, we will determine the
amount of time allotted to each
presenter and the approximate time
each oral presentation is to begin, and
will select and notify participants by
September 5, 2018. All requests to make
oral presentations must be received by
the close of registration on September 4,
2018. If selected for presentation, any
presentation materials must be emailed
to Tisha Washington (see FOR FURTHER
INFORMATION CONTACT) no later than
close of business, September 6, 2018. No
commercial or promotional material
will be permitted to be presented or
distributed at the public workshop.
Streaming Webcast of the Public
Workshop: This public workshop will
also be webcast. The webcast link will
be available on the following web page
5 days before the workshop at: https://
www.fda.gov/Drugs/NewsEvents/
ucm611203.htm.
If you have never attended a Connect
Pro event before, test your connection at
https://collaboration.fda.gov/common/
help/en/support/meeting_test.htm. To
get a quick overview of the Connect Pro
program, visit https://www.adobe.com/
go/connectpro_overview. FDA has
verified the website addresses in this
document, as of the date this document
publishes in the Federal Register, but
websites are subject to change over time.
Transcripts: Please be advised that as
soon as a transcript of the public
workshop is available, it will be
accessible at https://
www.regulations.gov. It may be viewed
at the Dockets Management Staff (HFA–
305), Food and Drug Administration,
5630 Fishers Lane, Rm. 1061, Rockville,
MD 20852. A link to the transcript will
also be available on the internet at
https://www.fda.gov/Drugs/NewsEvents/
ucm611203.htm.
VerDate Sep<11>2014
19:03 Aug 09, 2018
Jkt 244001
Dated: August 6, 2018.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2018–17130 Filed 8–9–18; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
HHS Approval of Entities That Certify
Medical Review Officers
Substance Abuse and Mental
Health Services Administration, HHS.
ACTION: Notice.
AGENCY:
This notice publishes a list of
the Department of Health and Human
Services (HHS) approved Medical
Review Officers certification entities.
The HHS Mandatory Guidelines for
Federal Workplace Drug Testing
Programs (Mandatory Guidelines),
applicable on October 1, 2017,
addresses the role and qualifications of
Medical Review Officers (MROs) and
HHS approval of entities that certify
MROs.
FOR FURTHER INFORMATION CONTACT:
Sean J. Belouin, Pharm.D., CAPT,
United States Public Health Service,
Senior Pharmacology and Regulatory
Policy Advisor, Substance Abuse and
Mental Health Services Administration,
5600 Fishers Lane, Room 16N06D,
Rockville, Maryland 20857; Telephone:
(240) 276–2716; Email: sean.belouin@
samhsa.hhs.gov.
SUPPLEMENTARY INFORMATION: Subpart
M—Medical Review Officer (MRO),
Section 13.2 of the Mandatory
Guidelines, ‘‘How are nationally
recognized entities or subspecialty
boards that certify MROs approved?’’
states as follows: ‘‘All nationally
recognized entities or subspecialty
boards which seek approval by the
Secretary to certify physicians as MROs
for federal workplace drug testing
programs must submit their
qualifications, a sample examination,
and other necessary supporting
examination materials (e.g., answers,
previous examination statistics or other
background examination information, if
requested) (OMB Control No.: 0930–
0158). Approval will be based on an
objective review of qualifications that
include a copy of the MRO applicant
application form, documentation that
the continuing education courses are
accredited by a professional
organization, and the delivery method
and content of the examination. Each
approved MRO certification entity must
SUMMARY:
PO 00000
Frm 00107
Fmt 4703
Sfmt 4703
39763
resubmit their qualifications for
approval every two years. The Secretary
shall publish at least every two years a
notice in the Federal Register listing
those entities and subspecialty boards
that have been approved. This notice is
also available on the internet at https://
www.samhsa.gov/workplace/drugtesting.’’
HHS has completed its review of
entities that certify MROs, in
accordance with requests submitted by
such entities to HHS.
The HHS Secretary approves the
following MRO certifying entities that
offer MRO certification through
examination:
American Association of Medical
Review Officers (AAMRO), P.O. Box
12873, Research Triangle Park, NC
27709, Phone: (919) 489–5407, Fax:
(919) 490–1010, Email: bbrandon@
aamro.com, website: https://
www.aamro.com/.
Medical Review Officer Certification
Council (MROCC), 3231 S. Halsted St,
#167, Chicago, IL 60608, Phone: (847)
631–0599, Fax: (847) 483–1282,
Email: mrocc@mrocc.org, website:
https://www.mrocc.org/.
DATES: HHS approval is effective July
31, 2018.
Alex M. Azar II,
Secretary.
[FR Doc. 2018–17184 Filed 8–9–18; 8:45 am]
BILLING CODE 4162–20–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Alcohol Abuse
and Alcoholism; Notice of Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the National Advisory
Council on Alcohol Abuse and
Alcoholism.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
E:\FR\FM\10AUN1.SGM
10AUN1
39764
Federal Register / Vol. 83, No. 155 / Friday, August 10, 2018 / Notices
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Advisory
Council on Alcohol Abuse and Alcoholism.
Closed: September 13, 2018.
Time: 9:00 a.m. to 9:45 a.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
National Institute on Alcohol Abuse and
Alcoholism, 6700–B Rockledge Drive,
Conference Rooms A & B, Bethesda, MD
20817.
Open: September 13, 2018.
Time: 9:45 a.m. to 3:00 p.m.
Agenda: Presentations and other business
of the Council.
Place: National Institutes of Health,
National Institute on Alcohol Abuse and
Alcoholism, 6700–B Rockledge Drive,
Conference Rooms A & B, Bethesda, MD
20817.
Contact Person: Abraham P. Bautista,
Ph.D., Executive Secretary, National
Advisory Council, National Institute on
Alcohol Abuse and Alcoholism, National
Institutes of Health, 6700–B Rockledge Drive,
Suite 1458, MSC 6902, Bethesda, MD 20892,
301–443–9737 bautista@mail.nih.gov.
Information is also available on the
Institute’s/Center’s home page: https://
www.niaaa.nih.gov/news-events/meetingsevents-exhibits, where an agenda and any
additional information for the meetings will
be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.271, Alcohol Research
Career Development Awards for Scientists
and Clinicians; 93.272, Alcohol National
Research Service Awards for Research
Training; 93.273, Alcohol Research Programs;
93.891, Alcohol Research Center Grants;
93.701, ARRA Related Biomedical Research
and Research Support Awards, National
Institutes of Health, HHS)
Dated: August 6, 2018.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2018–17107 Filed 8–9–18; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
daltland on DSKBBV9HB2PROD with NOTICES
National Institute on Aging; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
VerDate Sep<11>2014
19:03 Aug 09, 2018
Jkt 244001
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Aging Special Emphasis Panel; ADC P30
Review.
Date: September 17–18, 2018.
Time: 2:00 p.m. to 1:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton Garden Inn, 7301 Waverly
St., Bethesda, MD 20814.
Contact Person: Maurizio Grimaldi, MD,
Ph.D., Scientific Review Officer, National
Institute on Aging, National Institutes of
Health, 7201 Wisconsin Avenue, Room
2C218, Bethesda, MD 20892, 301–496–9374,
grimaldim2@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, Aging Research,
National Institutes of Health, HHS)
Dated: August 6, 2018.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2018–17103 Filed 8–9–18; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Chronic Pain: The Science of
Complementary and Integrative Health
Approaches
AGENCY:
National Institutes of Health,
HHS.
ACTION:
Notice.
This symposium on
September 11, 2018, sponsored by the
National Center for Complementary and
Integrative Health, will bring leading
researchers to discuss the science and
potential uses of complementary and
integrative health approaches in treating
chronic pain.
DATES: The meeting will be held on
September 11, 2018, from 8:30 a.m. to
5:30 p.m.
ADDRESSES: The meeting will be held at
the Boston Convention and Exhibition
Center, 415 Summer Street, Boston, MA
02210.
FOR FURTHER INFORMATION CONTACT: For
information concerning this meeting,
see the NCCIH website, https://
nccih.nih.gov/chronic-pain-symposium2018?nav=govd, the 17th World
Congress on Pain website, https://
www.iaspworldcongressonpain.org/
program/current-satellite-symposia/
SUMMARY:
PO 00000
Frm 00108
Fmt 4703
Sfmt 4703
#toggle-id-3, or contact Dr. Wen Chen,
Acting Branch Chief and Program
Director, Basic and Mechanistic
Research, Division of Extramural
Research, National Center for
Complementary and Integrative Health,
6707 Democracy Boulevard, Suite 401,
Bethesda, MD 20892, telephone: 301–
451–3989; email: when.chen2@nih.gov.
This
symposium, sponsored by the National
Center for Complementary and
Integrative Health, will bring leading
researchers from multiple disciplines to
discuss the science and potential uses of
complementary and integrative health
approaches in treating chronic pain. The
symposium will highlight current
concerns regarding the opioid epidemic
and the potential roles of
complementary and integrative health
approaches in addressing this crisis.
The objectives of the symposia are to:
Present the past, present, and future of
natural products research and pain
management, focusing on our current
understanding of the ascending and
descending neural mechanisms by
which different natural products may
contribute to analgesia; ascertain the
mechanisms by which a variety of mind
and body approaches may modulate
pain; and discuss translational potential
for complementary and integrative
approaches for individual-based chronic
pain management.
Interested individuals can register for
the symposia at: https://www.iaspworld
congressonpain.org/registration/. Once
you have created a free IASP account,
you can choose to register for a Satellite
Symposium only. Choose the Satellite
Symposium ‘‘Chronic Pain: The Science
of Complementary and Integrative
Health Approaches.’’ The registration
fee is $20 for the 1-day symposium.
SUPPLEMENTARY INFORMATION:
Dated: August 6, 2018.
David Shurtleff,
Acting Director, National Center for
Complementary and Integrative Health,
National Institutes of Health.
[FR Doc. 2018–17118 Filed 8–9–18; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Alcohol Abuse
and Alcoholism; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
E:\FR\FM\10AUN1.SGM
10AUN1
]]>Agencies
[Federal Register Volume 83, Number 155 (Friday, August 10, 2018)]
[Notices]
[Pages 39763-39764]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-17107]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute on Alcohol Abuse and Alcoholism; Notice of
Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of a meeting of the National Advisory
Council on Alcohol Abuse and Alcoholism.
The meeting will be open to the public as indicated below, with
attendance limited to space available. Individuals who plan to attend
and need special assistance, such as sign language interpretation or
other reasonable accommodations, should notify the Contact Person
listed below in advance of the meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material,
[[Page 39764]]
and personal information concerning individuals associated with the
grant applications, the disclosure of which would constitute a clearly
unwarranted invasion of personal privacy.
Name of Committee: National Advisory Council on Alcohol Abuse
and Alcoholism.
Closed: September 13, 2018.
Time: 9:00 a.m. to 9:45 a.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, National Institute on
Alcohol Abuse and Alcoholism, 6700-B Rockledge Drive, Conference
Rooms A & B, Bethesda, MD 20817.
Open: September 13, 2018.
Time: 9:45 a.m. to 3:00 p.m.
Agenda: Presentations and other business of the Council.
Place: National Institutes of Health, National Institute on
Alcohol Abuse and Alcoholism, 6700-B Rockledge Drive, Conference
Rooms A & B, Bethesda, MD 20817.
Contact Person: Abraham P. Bautista, Ph.D., Executive Secretary,
National Advisory Council, National Institute on Alcohol Abuse and
Alcoholism, National Institutes of Health, 6700-B Rockledge Drive,
Suite 1458, MSC 6902, Bethesda, MD 20892, 301-443-9737
[email protected].
Information is also available on the Institute's/Center's home
page: https://www.niaaa.nih.gov/news-events/meetings-events-exhibits, where an agenda and any additional information for the
meetings will be posted when available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.271,
Alcohol Research Career Development Awards for Scientists and
Clinicians; 93.272, Alcohol National Research Service Awards for
Research Training; 93.273, Alcohol Research Programs; 93.891,
Alcohol Research Center Grants; 93.701, ARRA Related Biomedical
Research and Research Support Awards, National Institutes of Health,
HHS)
Dated: August 6, 2018.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2018-17107 Filed 8-9-18; 8:45 am]
BILLING CODE 4140-01-P
